ClinConnect ClinConnect Logo
Search / Trial NCT05773300

Registry for Mayo Clinic Adult Congenital Heart Disease Control Population

Launched by MAYO CLINIC · Mar 10, 2023

Trial Information

Current as of August 20, 2025

Recruiting

Keywords

ClinConnect Summary

The Mayo Clinic is conducting a study to gather information about healthy adults to compare with data from individuals who have congenital heart disease. This research aims to better understand the differences and similarities between healthy individuals and those with heart conditions. If you are between the ages of 18 and 75, have a body mass index (BMI) of 30 or lower, and are not taking any heart medications, you might be eligible to participate. You should also have normal blood pressure and be able to understand and agree to take part in the study.

Participants in this trial will go through some screening tests to ensure they meet the eligibility requirements. It’s important to note that individuals with a history of heart problems or certain kidney issues won't be able to join this study. If you qualify, participating will help researchers gather valuable information that could improve care for people with congenital heart disease. Your involvement could make a difference in understanding heart health for everyone!

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • BMI ≤ 30.
  • No current cardiac medications.
  • Systolic BP ≤ 140 mmHg.
  • Diastolic BP ≤ 90 mmHg.
  • Capacity to consent.
  • Exclusion Criteria:
  • To be assessed via EMR screening.
  • Patient confirmation during screening visit.
  • Screening tests as applicable.
  • History of cardiovascular disease. eGFR \< 30.
  • Current orthopedic limitations.

About Mayo Clinic

Mayo Clinic is a renowned nonprofit medical practice and research institution dedicated to providing comprehensive healthcare and advancing medical knowledge through innovative research and education. With a commitment to patient-centered care, Mayo Clinic conducts numerous clinical trials aimed at exploring new therapies and improving treatment outcomes across various disciplines. Leveraging a multidisciplinary approach, the institution collaborates with leading experts and cutting-edge technology to ensure rigorous scientific standards and ethical practices in all its research endeavors. Through its trials, Mayo Clinic seeks to translate breakthroughs in science into tangible benefits for patients, fostering advancements in medicine that enhance health and quality of life.

Locations

Rochester, Minnesota, United States

Patients applied

PR

MB

2 patients applied

Trial Officials

Alexander Egbe, MBBS, MPH

Principal Investigator

Mayo Clinic

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials